potassium citrate

Generic: potassium citrate

Labeler: camber pharmaceuticals, inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium citrate
Generic Name potassium citrate
Labeler camber pharmaceuticals, inc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

potassium citrate 10 meq/1

Manufacturer
Camber Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 31722-130
Product ID 31722-130_cb7e4f56-0ffe-4809-991c-1751b62e63c7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214420
Listing Expiration 2026-12-31
Marketing Start 2021-02-15

Pharmacologic Class

Classes
acidifying activity [moa] anti-coagulant [epc] calcium chelating activity [moa] calculi dissolution agent [epc] decreased coagulation factor activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722130
Hyphenated Format 31722-130

Supplemental Identifiers

RxCUI
199376 199381 898490
UPC
0331722130011 0331722129015 0331722132015
UNII
EE90ONI6FF

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium citrate (source: ndc)
Generic Name potassium citrate (source: ndc)
Application Number ANDA214420 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 meq/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-130-01)
source: ndc

Packages (1)

Ingredients (1)

potassium citrate (10 meq/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cb7e4f56-0ffe-4809-991c-1751b62e63c7", "openfda": {"upc": ["0331722130011", "0331722129015", "0331722132015"], "unii": ["EE90ONI6FF"], "rxcui": ["199376", "199381", "898490"], "spl_set_id": ["ea933654-e8d2-4662-9a9a-4a6d79a9fb20"], "manufacturer_name": ["Camber Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-130-01)", "package_ndc": "31722-130-01", "marketing_start_date": "20210215"}], "brand_name": "POTASSIUM CITRATE", "product_id": "31722-130_cb7e4f56-0ffe-4809-991c-1751b62e63c7", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Acidifying Activity [MoA]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Decreased Coagulation Factor Activity [PE]"], "product_ndc": "31722-130", "generic_name": "Potassium Citrate", "labeler_name": "Camber Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "POTASSIUM CITRATE", "active_ingredients": [{"name": "POTASSIUM CITRATE", "strength": "10 meq/1"}], "application_number": "ANDA214420", "marketing_category": "ANDA", "marketing_start_date": "20210215", "listing_expiration_date": "20261231"}